These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2883018)

  • 41. A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats.
    Castillo C; Bobadilla RA; Ibarra M; Castillo EF; Hong E
    Arch Med Res; 1995; 26(3):251-5. PubMed ID: 8580676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of ventrolateral medulla in sympatholytic effect of 8-OHDPAT in rats.
    Nosjean A; Guyenet PG
    Am J Physiol; 1991 Mar; 260(3 Pt 2):R600-9. PubMed ID: 1672057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
    Claustre Y; Benavides J; Scatton B
    J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective irreversible blockade of 5-hydroxytryptamine1A and 5-hydroxytryptamine1C receptor binding sites in the rat brain by 8-MeO-2'-chloro-PAT: a quantitative autoradiographic study.
    Radja F; Daval G; Emerit MB; Gallissot MC; Hamon M; Vergé D
    Neuroscience; 1989; 31(3):723-33. PubMed ID: 2531850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat.
    Valenta B; Singer EA
    Br J Pharmacol; 1990 Apr; 99(4):713-6. PubMed ID: 1972893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha 2 receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in mice.
    Millan MJ; Colpaert FC
    Brain Res; 1991 Jan; 539(2):342-6. PubMed ID: 1675912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postdecapitation convulsions in the rat measured with an Animex motility meter: relation to central alpha-adrenoceptors.
    Vetulani J; Pilc A
    Eur J Pharmacol; 1982 Dec; 85(3-4):269-75. PubMed ID: 6129989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
    J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist.
    Liau LM; Sleight AJ; Pitha J; Peroutka SJ
    Pharmacol Biochem Behav; 1991 Mar; 38(3):555-9. PubMed ID: 1648748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion.
    Lucki I
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1120-7. PubMed ID: 2974486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD; Wright RN; Margraf RR; Eison AS
    Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
    Lorens SA; Van de Kar LD
    Neuroendocrinology; 1987 Apr; 45(4):305-10. PubMed ID: 2952898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.